Nonrulemaking

Requests that the FDA declare that the drug product, Bupropion Hydrochloride Tablets 150 mg is suitable for submission in an Abbreviated New Drug Application.

Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

📄 Primary document
OtherJun 24, 2026
Final Response
No comment period
Open →